• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTPA2QQ
Device Problems Battery Problem (2885); Impedance Problem (2950)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/01/2023
Event Type  malfunction  
Event Description
It was reported that the right ventricular (rv) lead defib impedance had dropped and that low pacing impedance was noted.The rv lead also exhibited increased thresholds but were stable.It was also reported that the left ventricular (lv) lead exhibited high thresholds.It was later reported that high and variable lv thresholds were potentially causing loss of capture at times and impacting battery longevity of the cardiac resynchronization therapy defibrillator (crt-d).Reprogramming of the lv lead was attempted but was unsuccessful.The rv lead exhibited high thresholds.It was also noted that the drop in rv defibrillation impedance was possibly due to a crt-d programming setting where the superior vena cava (svc) defibrillation coil was programmed on when the rv lead did not have an svc coil.The defibrillation impedance dropped in half when the svc coil was programmed off.The crt-d and leads remains in use.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key19030710
MDR Text Key339216446
Report Number9614453-2024-01317
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00763000178093
UDI-Public00763000178093
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/28/2023
Device Model NumberDTPA2QQ
Device Catalogue NumberDTPA2QQ
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/06/2024
Initial Date FDA Received04/03/2024
Date Device Manufactured02/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
5076-45 LEAD, 6935M55 LEAD, 429888 LEAD
Patient Age77 YR
Patient SexMale
Patient Weight83 KG
-
-